Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

3.7

Margin Of Safety %

-3

Put/Call OI Ratio

0.64

EPS Next Q Diff

-0.26

EPS Last/This Y

3.03

EPS This/Next Y

0.45

Price

90.6

Target Price

107

Analyst Recom

1.82

Performance Q

8.6

Upside

-25.0%

Beta

1.06

Ticker: GMED




17 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-01-23GMED92.540.640.0113474
2026-01-26GMED92.980.640.4813522
2026-01-27GMED91.940.640.1413540
2026-01-28GMED91.850.630.9313769
2026-01-29GMED90.220.640.1313865
2026-01-30GMED90.70.640.0013872
2026-02-02GMED89.730.620.1114069
2026-02-04GMED87.070.650.0514234
2026-02-05GMED87.510.640.0614338
2026-02-06GMED87.780.640.2814354
2026-02-09GMED87.60.640.0314455
2026-02-10GMED88.730.650.2714427
2026-02-11GMED88.260.650.3414603
2026-02-12GMED87.190.650.0714669
2026-02-13GMED88.090.652.4814765
2026-02-18GMED90.140.650.3014813
2026-02-19GMED90.960.640.5015242
DateSymbolLatestP/C OIP/C VolTotal OI
17 items Current Page1 of 1




17 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-01-23GMED92.5435.3- 3.79
2026-01-26GMED92.9735.3- 3.79
2026-01-27GMED91.9335.3- 3.79
2026-01-28GMED91.8636.3- 3.79
2026-01-29GMED90.2136.3- 3.79
2026-01-30GMED90.7036.3- 3.79
2026-02-02GMED89.7136.3- 3.79
2026-02-03GMED87.4937.3- 3.79
2026-02-04GMED87.0637.3- 3.79
2026-02-05GMED87.5137.3- 3.79
2026-02-06GMED87.8137.3- 3.79
2026-02-09GMED87.6037.3- 3.79
2026-02-10GMED88.7337.3- 3.79
2026-02-12GMED87.1737.3- 3.79
2026-02-18GMED90.1437.3- 3.79
2026-02-19GMED90.9637.3- 3.79
2026-02-20GMED90.6037.3- 3.79
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
17 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-01-23GMED-0.452.893.83
2026-01-26GMED-0.452.303.83
2026-01-27GMED-0.452.303.83
2026-01-28GMED-0.452.303.48
2026-01-29GMED-0.452.303.48
2026-01-30GMED-0.452.303.48
2026-02-02GMED-0.451.293.48
2026-02-03GMED-0.451.293.48
2026-02-04GMED-0.451.293.48
2026-02-05GMED-0.451.293.48
2026-02-06GMED-0.451.293.48
2026-02-09GMED-0.45-0.763.48
2026-02-10GMED-0.45-0.763.48
2026-02-11GMED-0.45-0.763.70
2026-02-12GMED-0.45-0.763.70
2026-02-13GMED-0.45-0.763.70
2026-02-17GMED-0.453.873.70
2026-02-18GMED-0.493.873.70
2026-02-19GMED-0.493.873.70
2026-02-20GMED-0.493.873.70
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

1.18

Avg. EPS Est. Current Quarter

1.09

Avg. EPS Est. Next Quarter

0.92

Insider Transactions

-0.49

Institutional Transactions

3.87

Beta

1.06

Average Sales Estimate Current Quarter

778

Average Sales Estimate Next Quarter

734

Fair Value

87.48

Quality Score

74

Growth Score

98

Sentiment Score

96

Actual DrawDown %

10.7

Max Drawdown 5-Year %

-47.9

Target Price

107

P/E

29.28

Forward P/E

21.75

PEG

1.61

P/S

4.4

P/B

2.77

P/Free Cash Flow

21.04

EPS

3.09

Average EPS Est. Cur. Y​

3.79

EPS Next Y. (Est.)

4.24

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

15.3

Relative Volume

0.65

Return on Equity vs Sector %

-19.4

Return on Equity vs Industry %

-8.1

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Globus Medical, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 5300
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary nailing, and regenerative biologic products; hip and knee joint solutions, including modular hip stems and acetabular cups for total hip arthroplasty, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants; and neuromonitoring services, which provides onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also offers enabling technologies, such as imaging, navigation, and robotics (INR) solutions for assisted surgery, which includes the ExcelsiusGPS platform, a robotic guidance and navigation system for minimally invasive and open procedures with screw and interbody spacer placement applications; Surgimap, a surgical planning software platform; Excelsius3D, a platform combined with ExcelsiusGPS that provides an intraoperative, image-guided robotic navigation solution; ExcelsiusHub, which provides real-time patient array monitoring, tissue sparing drills, and registration flexibility; and ExcelsiusFlex, a total knee arthroplasty robotic solution. Further, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
stock quote shares GMED – Globus Medical, Inc. Stock Price stock today
news today GMED – Globus Medical, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch GMED – Globus Medical, Inc. yahoo finance google finance
stock history GMED – Globus Medical, Inc. invest stock market
stock prices GMED premarket after hours
ticker GMED fair value insiders trading